Call to arrange a consultation
+1 416 777 0888

Court Proceedings

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,621,273 and 2,659,770 (macitentan)

Macitentan
T-769-20
Janssen Inc. et al. v JAMP Pharma Corp.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)

Saxagliptin
T-28-20
AstraZeneca Canada Inc. et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Application for leave to appeal to the Supreme Court of Canada in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)

Infliximab
39099
Hospira Healthcare Corporation et al. v The Kennedy Institute of Rheumatology
Biosimilars
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations relating  to Patent No. 2,752,550 (pomalidomide)

Pomalidomide
T-510-20
Celgene Inc. et al. v Dr. Reddy's Laboratories Ltd et al.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations relating  to Patent No. 2,794,060 (pomalidomide)

Pomalidomide
T-511-20
Celgene Inc. et al. v Dr. Reddy's Laboratories Ltd et al.
New PM(NOC) Regulations
Pending

Appeal of a trademark expungement case regarding Registration Nos. TMDA22577 and UCA44562 (HORLICKS)

A-121-19
Bedessee Imports Ltd. v GlaxoSmithKline Consumer Healthcare (UK) IP Limited
Trademark
Resolved

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)

Apixaban
T-503-19
Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)

Apixaban
T-504-19
Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,344,318 and 2,743,326 (daptomycin)

Daptomycin
T-1387-19
Cubist Pharmaceuticals LLC et al. v Dr. Reddy's Laboratories Limited et al.
New PM(NOC) Regulations
Pending

Patent infringement regarding Patent No. 2,743,326 (daptomycin)

Daptomycin
T-518-19
Cubist Pharmaceuticals LLC et al. v Sandoz Canada Inc.
Patent Infringement
Resolved

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,762,013 and 2,620,380 (pirfenidone)

Pirfenidone
T-704-19; T-705-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,937,365 (pirfenidone)

Pirfenidone
T-706-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,620,380 (pirfenidone)

Pirfenidone
T-708-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,631,646 (pirfenidone)

Pirfenidone
T-768-19; T-770-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,667,654 (pirfenidone)

Pirfenidone
T-896-19; T-897-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,709,997 (pirfenidone)

Pirfenidone
T-898-19; T-899-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,014 (pirfenidone)

Pirfenidone
T-939-19; T-941-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,358 (pirfenidone)

Pirfenidone
T-942-19; T-943-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,819,967 (pirfenidone)

Pirfenidone
T-1007-19; T-1008-19
Hoffmann-La Roche Limited et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Pending

Interlocutory appeal in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)

Infliximab
A-395-19; A-396-19; A-397-19
Hospira Healthcare Corporation et al. v The Kennedy Institute of Rheumatology
Biosimilars
Pending

Trademark opposition case regarding Registration No. 1,691,811 (INSTA-LOC)

2019 TMOB 146
InstaFibre Ltd. v Q.E.P. Co., Inc.
Trademark
Resolved (Interlocutory)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)

Silodosin
T-2023-18
Allergan Inc. v Sandoz Canada Inc. et al.
New PM(NOC) Regulations
Pending

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

Rivaroxaban
T-1960-18; T-2093-18; T-435-19; T-806-19
Bayer Inc. and Bayer Intellectual Property GmbH v Teva Canada Limited
New PM(NOC) Regulations
Resolved (Interlocutory)

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), TMA157,162 (ENERGIZER) and TMA740,338 (ENERGIZER)

A-357-18
Energizer Brands, LLC et al. v The Gillette Company et al.
Trademark
Resolved (Interlocutory)

Motion/Application under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)

Trastuzumab
T-317-18
Genentech Inc. v Pfizer Canada Inc.
New PM(NOC) Regulations
Resolved

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)

Trastuzumab
T-401-18
Hoffmann-La Roche Limited et al. v Pfizer Canada Inc.
New PM(NOC) Regulations
Resolved

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)

Trastuzumab
T-402-18
Hoffmann-La Roche Limited et al. v Pfizer Canada Inc.
New PM(NOC) Regulations
Resolved

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-329-18
Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.
Biosimilars
Resolved (Interlocutory)

Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-338-18
Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.
Biosimilars
Resolved

Statutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-354-18
Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.
Biosimilars
Resolved

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-336-18
Janssen Inc. et al. v Pfizer Canada Inc. et al.
Biosimilars
Resolved (Interlocutory)

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-360-18
Kennedy Trust for Rheumatology Research v Hospira Healthcare Corporation
Biosimilars
Resolved

Trademark infringement action against the owner of a s. 9 mark

A-355-18
Ontario (Energy) v Quality Program Services Inc.
Trademark
Resolved

CIRA domain name dispute relating to the domain name STRIPMEISTER.CA

CIRA
Wire Strip Meister Inc. and Copper Wire Stripper Ltd.
Trademark
Resolved

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding  Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

Rivaroxaban
T-806-19
Bayer Inc. et al. v Sandoz Canada Inc.
New PM(NOC) Regulations
Resolved (Interlocutory)

Trademark expungement regarding Registration Nos. TMDA22577 and UCA44562 (HORLICKS)

T-1746-17
Bedessee Imports Ltd. v GlaxoSmithKline Consumer Healthcare (UK) IP Limited
Trademark
Resolved (Appealed: A-121-19)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,477,301, 2,688,709, 2,476,983, 2,688,694, 2,537,092, 2,687,927, 2,688,695, 2,741,575, 2,688,708, 2,687,924 and 2,741,412 (lenalidomide)

Lenalidomide
T-1143-17
Celgene Inc. et al. v Dr. Reddy's Laboratories Ltd et al.
Old PM(NOC) Regulations
Resolved

Trademark expungement regarding Registration No. TMA400474 (RED BARN)

2017 TMOB 140
Keurig Green Mountain, Inc. v Bedessee Imports Ltd.
Trademark
Resolved

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,415,403 (acetaminophen)

Acetaminophen
T-1683-17
Mallinckrodt Hospital Products Inc. v Avir Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,705,733 (acetaminophen)

Acetaminophen
T-1684-17
Mallinckrodt Hospital Products Inc. v Avir Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Patent infringement case regarding Patent No. 2,407,556 (trastuzumab)

Trastuzumab
T-869-17
Pfizer Canada Inc. v Genentech Inc.
Patent Impeachment
Resolved

Patent impeachment case regarding Patent No. 2,540,547 (trastuzumab)

Trastuzumab
T-876-17
Pfizer Canada Inc. v Genentech Inc.
Patent Impeachment
Resolved

Patent impeachment case regarding Patent No. 2,329,829 (trastuzumab)

Trastuzumab
T-1239-17
Pfizer Canada Inc. v Genentech Inc.
Patent Impeachment
Resolved

Patent impeachment case regarding Patent No. 2,376,596 (trastuzumab)

Trastuzumab
T-1269-17
Pfizer Canada Inc. v Genentech Inc.
Patent Impeachment
Resolved

Patent impeachment case regarding Patent No. 2,596,133 (trastuzumab)

Trastuzumab
T-1270-17
Pfizer Canada Inc. v Genentech Inc.
Patent Impeachment
Resolved

Patent infringement case regarding Patent No. 2,787,952 (bevacizumab) with counterclaim for infringement under the new Patented Medicines (Notice of Compliance) Regulations

Bevacizumab
T-1471-17
Pfizer Canada Inc. v Genentech Inc. et al.
Patent Impeachment; New PM(NOC) Regulations
Resolved

Interlocutory decision in a trademark infringement action

CV-10-8839-00CL
Western Steel and Tube Ltd. v Technoflanage Inc.
Trademark
Resolved (Interlocutory)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,366,785 and 2,476,934 (etanercept)

Etanercept
T-1057-16
Amgen Canada Inc. et al. v Sandoz Canada Inc. et al.
Old PM(NOC) Regulations
Resolved

Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-327-16
Hospira Healthcare Corporation v Kennedy Institute of Rheumatology
Biosimilars
Resolved

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-326-16
Hospira Healthcare Corporation v Kennedy Trust for Rheumatology Research
Biosimilars
Resolved (Interlocutory)

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-328-16
Hospira Healthcare Corporation v Kennedy Trust for Rheumatology Research
Biosimilars
Resolved (Interlocutory)

Application under s. 18.1 of the old Patented Medicines (Notice of Compliance) Regulations  regarding Patent No. 2,586,023 (sevelamer)

Sevelamer
T-650-16
Sanofi-Aventis Canada Inc. et al. v Accel Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Patent infringement case regarding Patent No. 2,677,529 (Mobile Airborne Contaminant Control Chamber)

T-1077-16
Timothy Zimmerman et al. v Duroair Technologies Inc. et al.
Patent Infringement
Resolved

Patent infringement case regarding Patent Nos. 2,475,076 and 2,522,321 (Hard Wood Floor Panels and Manufacturing)

T-2105-16
Unilin Beheer B.V. v Triforest Inc.
Patent Infringement
Resolved

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), 157,162 (ENERGIZER) and 740,338 (ENERGIZER)

T-1591-15
Energizer Brands, LLC v The Gillette Company
Trademark
Pending

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Infliximab
A-303-15
Hospira Healthcare Corporation v Kennedy Institute of Rheumatology
Patent Impeachment
Resolved (Interlocutory)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,261,630 (infliximab).

Infliximab
T-1478-15
Janssen Inc. v Celltrion Healthcare Co., Ltd.
Old PM(NOC) Regulations
Resolved (Appealed: A-208-16)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,166,483, 2,186,037, 1,338,377, 2,133762, 2,170,647, 2,290,963, 2,346,988, 2,166,794, 2,139,653, 2,180,535, 2,290,531, 2,226,184 and 2,193,994 (esomeprazole)

Esomeprazole
T-1200-15
Pharmascience Inc. v AstraZeneca Canada Inc.
Old PM(NOC)
Resolved

Trademark infringement case regarding Registration No. TMA396,079 (FREEDOMWALKER)

T-355-15
Sunburst Medical Inc. v Medline Canada Corp. et al.
Trademark
Resolved

Trademark infringement case regarding Registration No. TMA396,079 (FREEDOMWALKER)

T-1429-15
Sunburst Medical Inc. v Medline Canada Corp. et al.
Trademark
Resolved

Trademark opposition case regarding Registration No. 1,172,524 (DEMERARA)

2014 TMOB 101
Bedessee Imports Ltd. v Demerara Distillers Limited
Trademark
Resolved

Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulation regarding Patent Nos. 1,340,794 and 2,031,890 (pemetrexed).

Pemetrexed
T-366-14
Eli Lilly Canada Inc. v Hospira Healthcare Corporation et al.
Old PM(NOC) Regulations
Resolved

Action under section 8 of the old Patented Medicines (Notice of Compliance) Regulations regarding patent No. 2,327,285, 2,325,045, 2,297,163 and 2,134,674 (pregabalin).

Pregabalin
T-1434-14
Pharmascience Inc. v Pfizer Canada ULC
Old PM(NOC) Regulations
Pending

Judicial review application regarding Patent No. 2,261,630 (infliximab)

Infliximab
T-1516-14
Janssen Inc. et al. v Canada (Attorney General) et al.
Judicial Review
Resolved

Trademark infringement case regarding Registration No. TMA 624,752 (PINK)

T-1274-13
Victoria's Secret Brand Management, Inc. and Victoria's Secret (Canada) Corp. v Thomas Pink Limited
Trademark
Resolved

Patent impeachement and patent infringement case regarding Patent No. 2,261,630 (infliximab).

Infliximab
T-396-13
Hospira Healthcare Corporation v The Kennedy Institute of Rheumatology
Patent Impeachment
Pending

Patent infringement case regarding Patent No. 2,355,347 (quinapril)

Quinapril
T-1935-13
Bernard Charles Sherman et al. v Pharmascience Inc.
Patent Infringement
Pending

Patent infringement case regarding Patent No. 1,336,777 (clopidogrel).

Clopidogrel
T-2004-13
Sanofi et al. v Sandoz Canada Inc.
Patent Infringement
Resolved

Patent infringement case regarding Patent No. 1,336,777 (clopidogrel).

Clopidogrel
T-2009-13
Sanofi et al. v Pharmascience Inc. et al.
Patent Infringement
Resolved

Appeal in a patent infringement case regarding Patent No. 1,340,083 (valacyclovir).

Valacyclovir
A-397-13
Pharmascience Inc. et al. v Glaxosmithkline Inc. et al.
Patent Infringement
Resolved

Appeal in a patent infringement case regarding Patent No. 1,340,083 (valacyclovir).

Valacyclovir
A-398-13
Apotex Inc. v Glaxosmithkline Inc. et al.
Patent Infringement
Resolved

Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,372,576 and 2,219,475 (fenofibrate)

Fenofibrate
A-99-12
Sandoz Canada Inc. v Fournier Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Appeal of an application under subsection 6(1) the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,372,576 and 2,219,475 (fenofibrate)

Fenofibrate
A-100-12
Sandoz Canada Inc. v Fournier Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)

Fenofibrate
A-101-12
Sandoz Canada Inc. v Fournier Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)

Fenofibrate
A-102-12
Sandoz Canada Inc. v Fournier Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Appeal of an application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)

Fenofibrate
A-103-12
Sandoz Canada Inc. v Fournier Pharma Inc. et al.
Old PM(NOC) Regulations
Resolved

Trademark opposition case regarding Application No. 1,206,738 (DEMERARA GOLD)

2011 TMOB 102
Guyana Sugar Corporation v Bedessee Imports Ltd.
Trademark
Resolved

Trademark expungement case regarding Registration No. TMA528,477 (MYTHOS & Design)

2011 TMOB 211
Pacific Western Brewing Company Ltd. v Mythos Brewery SA
Trademark
Resolved

Action under to section 8 of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,267,136 and 2,325,014 (desloratadine)

Desloratadine
T-1807-11
Pharmascience Inc. v Schering-Plough Canada Inc. et al.
Old PM(NOC) Regulations
Resolved

Action under to section 8 of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,173,457 (finasteride)

Finasteride
T-2059-11
Pharmascience Inc. v Merck Canada Inc. et al.
Old PM(NOC) Regulations
Resolved

Trade mark opposition case regarding Application No. 1,321,379 (HYUNDAI & Design)

2010 TMOB 131
Hyundai Auto Canada Corp. v Hyundai Heavy Industries Co.
Trademark
Resolved

Action pursuant to section 8 of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 1,340,083 (valacyclovir)

Valacyclovir
T-643-10
Pharmascience Inc. v GlaxoSmithKline Inc.
Old PM(NOC) Regulations
Resolved

Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,372,576 and 2,219,475 (fenofibrate)

Fenofibrate
T-991-10
Fournier Pharma Inc. et al. v Minister of Health et al.
Old PM(NOC) Regulations
Resolved

Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,219,475 (fenofibrate)

Fenofibrate
T-1051-10
Fournier Pharma Inc. et al. v Minister of Health et al.
Old PM(NOC) Regulations
Resolved

Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)

Fenofibrate
T-1184-10
Fournier Pharma Inc. et al. v Minister of Health et al.
Old PM(NOC) Regulations
Resolved

Action under section 8 of the old Patented Medicines (Notice of Compliance) Regulations regarding multiple patents (atorvastatin)

Atorvastatin
T-1736-10
Apotex Inc. v Pfizer Canada Inc. et al.
Old PM(NOC) Regulations
Resolved

Appeal of a partial summary judgment decision regarding the ownership of Mill-Pac Black

C47431
Canadian Gasket & Supply Inc. v Industrial Gasket & Shim Company, Inc.
Ownership
Resolved

Appeal in a patent impeachment case regarding Patent No. 2,207,045 (Kit and Process for the Manufacture of a Set of Individual Pill Containers)

A-68-07
Distrimedic Inc. v Richards Packaging Inc.
Patent Impeachment
Resolved

Interlocutory motion in a patent impeachment case regarding Patent No. 2,207,045 (Kit and Process for the Manufacture of a Set of Individual Pill Containers)

T-92-06
Richards Packaging Inc. v Canada (Attorney General)
Patent Impeachment
Resolved

Patent infringement case regarding Patent No. 2,207,045 (Kit and Process for the Manufacture of a Set of Individual Pill Containers)

T-1591-05
Distrimedic Inc. v Dispill Inc.
Patent Infringement
Resolved

Trademark opposition case regarding Application No. 898,649 (POPEYE'S SAILORS EXCHANGE)

2004 CanLII 71778
Hearst Holdings, Inc. v Wallstrom (Popeye's Sailors Exchange)
Trademark
Resolved

Trademark opposition case regarding Application No. 801,053 (RED BOOK)

2000 TMOB 72
Hearst Communications, Inc. v Nesbitt Burns Corp. Ltd.
Trademark
Resolved

Appeal in a trademark expungement case regarding COUNTRY LIVING.

A-356-00
United Grain Growers Ltd. v Lang Michener
Trademark
Leave to appeal to SCC granted; Resolved

Appeal in a trademark opposition case regarding XP 2000, XP 2000 MS, XP 2000 AS, XP 2000 V, XP 2000 H, XP 2000 Z, AMERI WAY XT & DESIGN, AMERI XL 4 & DESIGN

T-2816-96
Compagnie Générale des Établissements Michelin-Michelin & Cie v Continental General Tire Canada Inc.
Trademark
Resolved